The Women’s Health Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
The rise in support and initiatives by government and NGOs is boosting the market growth
Globally there has been a rise in awareness of women’s health with all the governments and NGOs supporting through various funding and awareness programs. For instance, in 2021, Office on Women’s Health (OWH) which works with the parent organisation i.e. The U.S. Department of Health and Human Services (HHS) announced an initiative to enhance and improve maternal health data across the country through a US$8 million agreement with Premier Inc. Under this agreement a minimum of 200 would be deployed under evidence based best practices for maternal care. On June 2022, the White House announced the Biden-Harris Administration’s Blue Print to address the growing crisis of maternal health in the country. This blue print would mainly focus on providing Medicaid coverage for 12 months postpartum and additional investments to reduce maternal morbidity and mortality. Worldwide many organisations such as governments, private players and non-government organisations, multilateral agencies are collaborating towards developing innovative interdisciplinary solutions to improve women’s health
Impact on Women’s Health in underdeveloped regions
Understanding the impact of gynaecology related diseases in women is critical in developing a concerted and sustained global response towards reducing this burden. According to the WHO Millennium Goals Progress Report, the maternal mortality risk is 1: 30 in sub-Saharan Africa vs 1: 5600 in the developed countries. Major factors for high maternal and antenatal mortality include lack of education and inadequate maternal care. Approximately 45% to 50% women do not have access to basic antenatal care while 60 million births are conducted with no skilled healthcare professionals. Furthermore, adolescent pregnancy is the leading cause of death in low-income countries accounting for 15% of total maternal deaths across the globe and 26% occur in Africa. Additionally, around 85% cervical cancer related deaths occur in low-income and middle-income countries due to limited access to diagnosis and treatment. These factors urge a need for measures in preventing and treating Women’s Health in underdeveloped regions.
What Questions Should You Ask before Buying a Market Research Report?
• How is the Women’s Health market evolving?
• What is driving and restraining the Women’s Health market?
• How will each Women’s Health submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Women’s Health submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Women’s Health markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Women’s Health projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Women’s Health projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Women’s Health market?
• Where is the Women’s Health market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Women’s Health market today, and over the next 10 years:
• Our 242-page report provides 119 tables and 185 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Women’s Health market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Women’s Health prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Application
• Contraceptives
• Postmenopausal Osteoporosis
• Hormonal Infertility
• Menopause
• Polycystic Ovary Syndrome
• Endometriosis and Uterine Fibroids
• Other
Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Drugs
• Xgeva
• Prolia
• Mirena
• Forteo
• Premarin
• Lupron
• Lo Loestrin
• Orilissa/Oriahnn
Type
• Generics
• Branded
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Women’s Health Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Agile Therapeutics
• Allergan/AbbVie
• Amgen
• Apothecus Pharmaceutical Corp.
• Bayer Pharmaceuticals
• Eli Lilly and Company
• Ferring B.V.
• Merck
• Novartis
• Pfizer
Overall world revenue for Women’s Health Market, 2023 to 2033 in terms of value the market will surpass US$37,907 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Women’s Health Market, 2023 to 2033 report help you?
In summary, our 240+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Women’s Health Market, 2023 to 2033 , with forecasts for application, distribution channel, drugs, and type, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the Women’s Health Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Women’s Health Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Women’s Health Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Women’s Health Market Report 2023-2033: Forecasts by Application (Contraceptives, Postmenopausal Osteoporosis, Hormonal Infertility, Menopause, Polycystic Ovary Syndrome (PCOS), Endometriosis and Uterine Fibroids, Endometriosis, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies Online Pharmacies), by Type (Generics, Biologics), by Drugs (Xgeva, Prolia, Mirena, Forteom, Premarin, Lupron, Lo Loestrin, Orilissa/Oriahnn) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Women’s Health Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
2.1 Geographical Snapshot: Women’s Health Market
2.2 Application Segment: Market Attractiveness Index
2.3 Distribution Channel Segment: Market Attractiveness Index
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increased focus on developing economies
3.2.1.2 Increasing innovation for novel therapies
3.2.1.3 Increasing focus on adoption of technology for better patient experience
3.2.2 Market Restraining Factors
3.2.2.1 High Prices Are Restraining Growth of the Market
3.2.3 Market Opportunities
3.2.3.1 Rise in investments for advanced healthcare infrastructure
3.2.4 Challenges
3.2.4.1 Impact on women health in underdeveloped regions
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
4 Women’s Health Market Analysis by Application
4.1 Key Findings
4.2 Application Segment: Market Attractiveness Index
4.3 Women’s Health Market Size Estimation and Forecast by Application
4.4 Contraceptives
4.4.1 Contraceptives Market Forecast by Region, 2023-2033 (US$ Mn)
4.4.2 Contraceptives Market Share by Region, 2023-2033 (%)
4.5 Postmenopausal Osteoporosis
4.5.1 Postmenopausal Osteoporosis Market Forecast by Region, 2023-2033 (US$ Mn)
4.5.2 Postmenopausal Osteoporosis Market Share by Region, 2023-2033 (%)
4.6 Hormonal Infertility
4.6.1 Hormonal Infertility Market Forecast by Region, 2023-2033 (US$ Mn)
4.6.2 Hormonal Infertility Market Share by Region, 2023-2033 (%)
4.7 Menopause
4.7.1 Menopause Market Forecast by Region, 2023-2033 (US$ Mn)
4.7.2 Menopause Market Share by Region, 2023-2033 (%)
4.8 Polycystic Ovary Syndrome
4.8.1 Polycystic Ovary Syndrome Market Forecast by Region, 2023-2033 (US$ Mn)
4.8.2 Polycystic Ovary Syndrome Market Share by Region, 2023-2033 (%)
4.9 Endometriosis and Uterine Fibroids
4.9.1 Endometriosis and Uterine Fibroids Market Forecast by Region, 2023-2033 (US$ Mn)
4.9.2 Endometriosis and Uterine Fibroids Market Share by Region, 2023-2033 (%)
4.10 Other diseases
4.10.1 Other Diseases Market Forecast by Region, 2023-2033 (US$ Mn)
4.10.2 Other Application Market Share by Region, 2023-2033 (%)
5 Women’s Health Market Analysis by Distribution Channel
5.1 Key Findings
5.2 Distribution Channel Segment: Market Attractiveness Index
5.3 Women’s Health Market Size Estimation and Forecast by Distribution Channel
5.4 Women’s Health Market Share by Distribution Channel, 2023 & 2033
5.5 Hospital Pharmacies
5.5.1 Hospital Pharmacies Market Forecast by Region, 2023-2033 (US$ Mn)
5.5.2 Hospital Pharmacies Market Share by Region, 2023-2033 (%)
5.6 Retail Pharmacies
5.6.1 Retail Pharmacies Market Forecast by Region, 2023-2033 (US$ Mn)
5.6.2 Retail Pharmacies Market Share by Region, 2023-2033 (%)
5.7 Online Pharmacies
5.7.1 Online Pharmacies Market Forecast by Region, 2023-2033 (US$ Mn)
5.7.2 Online Pharmacies Market Share by Region, 2023-2033 (%)
6 Women’s Health Market Analysis by Drugs
6.1 Key Findings
6.2 Xgeva
6.2.1 Xgeva Market Forecast by Region, 2023-2033 (US$ Mn)
6.3 Prolia
6.3.1 Prolia Market Forecast by Region, 2023-2033 (US$ Mn)
6.4 Mirena
6.4.1 Mirena Market Forecast by Region, 2023-2033 (US$ Mn)
6.5 Forteo
6.5.1 Forteo Market Forecast by Region, 2023-2033 (US$ Mn)
6.6 Premarin
6.6.1 Premarin Market Forecast by Region, 2023-2033 (US$ Mn)
6.7 Lupron
6.7.1 Lupron Market Forecast by Region, 2023-2033 (US$ Mn)
6.8 Lo Loestrin
6.8.1 Lo Loestrin Market Forecast by Region, 2023-2033 (US$ Mn)
6.9 Orilissa/Oriahnn
6.9.1 Orilissa/Oriahnn Market Forecast by Region, 2023-2033 (US$ Mn)
7 Women’s Health Market Analysis by Generics/Branded
7.1 Key Findings
7.2 Type Segment: Market Attractiveness Index
7.3 Women’s Health Market Share by Generics/Branded, 2023 & 2033
7.3.1 Women’s Health Market, By Generics
7.3.1.1 Generic Drugs Market Size Estimation and Forecast
7.3.2 Women’s Health Market, By Branded Drugs
7.3.2.1 Branded Drugs Market Size Estimation and Forecast
8 Women’s Health Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America Women’s Health Market Analysis
9.1 Key Findings
9.2 North America Women’s Health Market Attractiveness Index
9.3 North America Women’s Health Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 North America Women’s Health Market Size Estimation and Forecast by Country
9.5 North America Women’s Health Market Size Estimation and Forecast by Application
9.6 North America Women’s Health Market Size Estimation and Forecast by Distribution Channel
9.7 U.S.
9.7.1 U.S. Women’s Health Market by Application
9.8 Canada
9.8.1 Canada Women’s Health Market by Application
10 Europe Women’s Health Market Analysis
10.1 Key Findings
10.2 Europe Women’s Health Market Attractiveness Index
10.3 Europe Women’s Health Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Europe Women’s Health Market Size Estimation and Forecast by Country
10.5 Europe Women’s Health Market Size Estimation and Forecast by Application
10.6 Europe Women’s Health Market Size Estimation and Forecast by Distribution Channel
10.7 Germany
10.7.1 Germany Women’s Health Market by Application
10.8 U.K.
10.8.1 U.K. Women’s Health Market by Application
10.9 France
10.9.1 France Women’s Health Market by Application
10.10 Italy
10.10.1 Italy Women’s Health Market by Application
10.11 Spain
10.11.1 Spain Women’s Health Market by Application
10.12 Rest of Europe
10.12.1 Rest of Europe Women’s Health Market by Application
11 Asia Pacific Women’s Health Market Analysis
11.1 Key Findings
11.2 Asia Pacific Women’s Health Market Attractiveness Index
11.3 Asia Pacific Women’s Health Market by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Asia Pacific Women’s Health Market Size Estimation and Forecast by Country
11.5 Asia Pacific Women’s Health Market Size Estimation and Forecast by Application
11.6 Asia Pacific Women’s Health Market Size Estimation and Forecast by Distribution Channel
11.7 Japan
11.7.1 Japan Women’s Health Market by Application
11.8 China
11.8.1 China Women’s Health Market by Application
11.9 India
11.9.1 India Women’s Health Market by Application
11.10 South Korea
11.10.1 South Korea Women’s Health Market by Application
11.11 Australia
11.11.1 Australia Women’s Health Market by Application
11.12 Rest of Asia Pacific
11.12.1 Rest of Asia Pacific Women’s Health Market by Application
12 Latin America Women’s Health Market Analysis
12.1 Key Findings
12.2 Latin America Women’s Health Market Attractiveness Index
12.3 Latin America Women’s Health Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Latin America Women’s Health Market Size Estimation and Forecast by Country
12.5 Latin America Women’s Health Market Size Estimation and Forecast by Application
12.6 Latin America Women’s Health Market Size Estimation and Forecast by Distribution Channel
12.7 Brazil
12.7.1 Brazil Women’s Health Market by Application
12.8 Mexico
12.8.1 Mexico Women’s Health Market by Application
12.9 Rest of Latin America
12.9.1 Rest of Latin America Women’s Health Market by Application
13 MEA Women’s Health Market Analysis
13.1 Key Findings
13.2 MEA Women’s Health Market Attractiveness Index
13.3 MEA Women’s Health Market by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 MEA Women’s Health Market Size Estimation and Forecast by Country
13.5 MEA Women’s Health Market Size Estimation and Forecast by Application
13.6 MEA Women’s Health Market Size Estimation and Forecast by Distribution Channel
13.7 South Africa
13.7.1 South Africa Women’s Health Market by Application
13.8 GCC
13.8.1 GCC Women’s Health Market by Application
13.9 Rest of MEA
13.9.1 Rest of MEA Women’s Health Market by Application
14 Competitive Landscape
14.1 Company Share Analysis
14.2 Key Business Strategy Analysis
15 Company Profiles
15.1 Pfizer
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.3.1 Net Revenue, 2019-2021
15.1.3.2 Regional Market Shares, 2021
15.1.3.3 Gross Profit, 2019-2021
15.1.3.4 R&D, 2019-2021
15.1.4 Product Benchmarking
15.1.5 Strategic Outlook
15.2 Merck
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue, 2019-2021
15.2.3.2 Regional Market Shares, 2021
15.2.3.3 Income from Continuing Operations Before Taxes, 2019-2021
15.2.3.4 R&D, 2019-2021
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 Bayer Pharmaceuticals
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2019-2021
15.3.3.2 Regional Market Shares, 2021
15.3.3.3 EBITDA, 2019-2021
15.3.3.4 R&D, 2019-2021
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Eli Lilly and Company
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2019-2021
15.4.3.2 Regional Market Shares, 2021
15.4.3.3 Net Income, 2019-2021
15.4.3.4 R&D, 2019-2021
15.4.4 Product Benchmarking
15.5 Amgen
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2019-2021
15.5.3.2 Regional Market Shares, 2021
15.5.3.3 Gross Profit, 2019-2021
15.5.3.4 R&D, 2019-2021
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Allergan/AbbVie
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2019-2021
15.6.3.2 Regional Market Shares, 2021
15.6.3.3 Operating Earnings, 2019-2021
15.6.3.4 R&D, 2019-2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Novartis
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2019-2021
15.7.3.2 Regional Market Shares, 2021
15.7.3.3 Gross Profit, 2019-2021
15.7.3.4 R&D, 2019-2021
15.7.4 Product Benchmarking
15.8 Agile Therapeutics
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Product Benchmarking
15.8.4 Strategic Outlook
15.9 Ferring B.V.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2019-2021
15.9.3.2 Regional Market Shares, 2021
15.9.3.3 Gross Profit, 2019-2021
15.9.3.4 R&D, 2019-2021
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Apothecus Pharmaceutical Corp.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Product Benchmarking
16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players
List of Tables
Table 1 Women’s Health Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Women's Health Market, By Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (V-shaped Recovery)
Table 3 Women's Health Market, By Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (U-shaped Recovery)
Table 4 Women's Health Market, By Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (W-shaped Recovery)
Table 5 Women's Health Market, By Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (L-shaped Recovery)
Table 6 Women's Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 7 List of Contraceptive drugs
Table 8 Contraceptives Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 9 Postmenopausal Osteoporosis Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 10 Hormonal Infertility Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 11 List of Menopause Medications
Table 12 Menopause Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 13 Polycystic Ovary Syndrome Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 14 Endometriosis and Uterine Fibroids Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 15 Other Indications Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 16 Women's Health Distribution Channel Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 17 Hospital Pharmacies Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 18 Retail Pharmacies Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 19 Online Pharmacies Market, by Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 20 Xgeva Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 21 Prolia Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 22 Mirena Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 23 Forteo Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 24 Premarin Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 25 Lupron Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 26 Lo Loestrin Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 27 Orilissa/Oriahnn Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 28 List of Generic Drugs
Table 29 Generic Drugs Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 30 List of Branded Drugs
Table 31 Brander Drugs Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 32 Women's Health Market, By Region, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 33 North America Women's Health Market, By Country, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 34 North America Women's Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 35 North America Gynecology Distribution Channel Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 36 US Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 37 US Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 38 Canada Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 39 Canada Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 40 Europe Women's Health Market, By Country, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 41 Europe Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 42 Europe Gynecology Distribution Channel Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 43 Germany Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 44 Germany Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 45 UK Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 46 UK Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 47 France Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 48 France Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 49 Italy Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 50 Italy Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 51 Spain Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 52 Spain Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 53 Rest of Europe Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 54 Rest of Europe Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 55 Asia Pacific Women's Health Market, By Country, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 56 Asia Pacific Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 57 Asia-Pacific Gynecology Distribution Channel Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 58 Japan Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 59 Japan Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 60 China Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 61 China Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 62 India Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 63 India Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 64 South Korea Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 65 South Korea Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 66 Australia Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 67 Australia Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 68 Rest of Asia Pacific Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 69 Rest of Asia Pacific Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 70 Latin America Women's Health Market, By Country, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 71 Latin America Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 72 Latin America Gynecology Distribution Channel Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 73 Brazil Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 74 Brazil Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 75 Mexico Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 76 Mexico Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 77 Rest of Latin America Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 78 Rest of Latin America Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 79 MEA Women's Health Market, By Country, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 80 MEA Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 81 MEA Gynecology Distribution Channel Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 82 South Africa Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 83 South Africa Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 84 GCC Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 85 GCC Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 86 Rest of MEA Women's Health Market, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 87 Rest of MEA Women’s Health Market by Application, 2023-2033 (US$ mn, AGR (%), CAGR (%))
Table 88 Key Business Strategies Adopted by Key Players in Women’s Health Market
Table 89 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Pfizer: Product Benchmarking
Table 91 Pfizer Inc: Company Product Pipeline
Table 92 Pfizer Inc: Company Recent Developments
Table 93 Merck: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Merck: Product Benchmarking
Table 95 Merck: Company Recent Developments
Table 96 Bayer Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Bayer Pharmaceuticals: Product Benchmarking
Table 98 Bayer Pharmaceuticals Inc: Company Product Pipeline
Table 99 Bayer Pharmaceuticals: Company Recent Developments
Table 100 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Eli Lilly and Company: Product Benchmarking
Table 102 Amgen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Amgen: Product Benchmarking
Table 104 Amgen: Strategic Outlook
Table 105 AbbVie: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 AbbVie: Product Benchmarking
Table 107 AbbVie: Company Recent Developments
Table 108 Novartis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Novartis: Product Benchmarking
Table 110 Agile Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Agile Therapeutics: Product Benchmarking
Table 112 Agile Therapeutics: Company Product Pipeline
Table 113 Agile Therapeutics: Company Recent Developments
Table 114 Ferring B.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Ferring B.V.: Product Benchmarking
Table 116 Ferring B.V.: Company Product Pipeline
Table 117 Ferring B.V.: Company Recent Developments
Table 118 Apothecus Pharmaceutical Corp.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Apothecus Pharmaceutical Corp.: Product Benchmarking
List of Figures
Figure 1 Women’s Health Market Segmentation
Figure 2 Women’s Health Market Forecast by Region: Market Attractiveness Index
Figure 3 Women’s Health Market by Application: Market Attractiveness Index
Figure 4 Women’s Health Market by Distribution Channel: Market Attractiveness Index
Figure 5 Women’s Health Market: Market Dynamics
Figure 6 COVID Impact Analysis: Women’s Health Market Recovery Scenarios
Figure 7 Women’s Health Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Women’s Health Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Women’s Health Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Women’s Health Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Women’s Health Market: Porter’s Five Forces Analysis
Figure 12 Women’s Health Market Forecast by Application 2023 (Revenue, CAGR%)
Figure 13 Women’s Health Market Share Forecast by Application, 2023 and 2033 (%)
Figure 14 Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 15 Contraceptives Market Forecast by Region, 2023-2033 (US$ million)
Figure 16 Contraceptives Market Share Forecast by Region, 2023, 2028, 2033 (%)
Figure 17 Postmenopausal Osteoporosis Market Forecast by Region, 2023-2033 (US$ million)
Figure 18 Postmenopausal Osteoporosis Market Share Forecast by Region, 2023, 2028, 2033 (%)
Figure 19 Hormonal Infertility Market Forecast by Region, 2023-2033 (US$ million)
Figure 20 Hormonal Infertility Market Share Forecast by Region, 2023-2033 (%)
Figure 21 Menopause Market Forecast by Region, 2023-2033 (US$ million)
Figure 22 Menopause Market Share Forecast by Region, 2023-2033 (%)
Figure 23 Polycystic Ovary Syndrome Market Forecast by Region, 2023-2033 (US$ million)
Figure 24 Polycystic Ovary Syndrome Market Share Forecast by Region, 2023, 2028, 2033 (%)
Figure 25 Endometriosis and Uterine Fibroids Market Forecast by Region, 2023-2033 (US$ million)
Figure 26 Endometriosis and Uterine Fibroids Market Share Forecast by Region, 2023, 2028, 2033 (%)
Figure 27 Other Application Market Forecast by Region, 2023-2033 (US$ million)
Figure 28 Other Application Market Share Forecast by Region, 2023, 2028, 2033 (%)
Figure 29 Women’s Health Market Forecast by Distribution Channel 2023 and 2033 (Revenue, CAGR%)
Figure 30 Women’s Health Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 31 Women’s Health Market Share Forecast by Distribution Channel, 2023, 2033 (%)
Figure 32 Hospital Pharmacies Market Forecast by Region, 2023-2033 (US$ million)
Figure 33 Hospital Pharmacies Market Share Forecast by Region, 2023, 2028, 2033 (%)
Figure 34 Retail Pharmacies Market Forecast by Region, 2023-2033 (US$ million)
Figure 35 Retail Pharmacies Market Share Forecast by Region, 2023, 2028, 2033 (%)
Figure 36 Online Pharmacies Market Forecast by Region, 2023-2033 (US$ million)
Figure 37 Online Pharmacies Market Share Forecast by Region, 2023, 2028, 2033 (%)
Figure 38 Xgeva Market Forecast, 2023-2033 (US$ million)
Figure 39 Prolia Market Forecast, 2023-2033 (US$ million)
Figure 40 Mirena Market Forecast, 2023-2033 (US$ million)
Figure 41 Forteo Market Forecast, 2023-2033 (US$ million)
Figure 42 Premarin Market Forecast, 2023-2033 (US$ million)
Figure 43 Lupron Market Forecast, 2023-2033 (US$ million)
Figure 44 Lo Loestrin Market Forecast, 2023-2033 (US$ million)
Figure 45 Orilissa/Oriahnn Market Forecast, 2023-2033 (US$ million)
Figure 46 Women’s Health Market Forecast by Generics/Branded 2023 (Revenue, CAGR%)
Figure 47 Women’s Health Market Share Forecast by Generics/Branded, 2023, 2033 (%)
Figure 48 Women’s Health Market Forecast by Generics, 2023-2033 (US$ million, AGR %)
Figure 49 Women’s Health Market Forecast by Branded, 2023-2033 (US$ million, AGR %)
Figure 50 Women’s Health Market Forecast by Region 2023 and 2033 (Revenue)
Figure 51 Women’s Health Market Share Forecast by Region 2023 and 2033(%)
Figure 52 Women’s Health Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Figure 53 North America Women’s Health Market Attractiveness Index, 2023
Figure 54 North America Women’s Health Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 55 North America Women’s Health Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 56 North America Women’s Health Market Share Forecast by Country, 2023 & 2033 (%)
Figure 57 North America Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 58 North America Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 59 North America Women’s Health Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 60 North America Women’s Health Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 61 U.S. Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 62 U.S. Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 63 U.S. Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 64 Canada Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 65 Canada Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 66 Canada Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 67 Europe Women’s Health Market Attractiveness Index
Figure 68 Europe Women’s Health Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 69 Europe Women’s Health Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 70 Europe Women’s Health Market Share Forecast by Country, 2023 & 2033 (%)
Figure 71 Europe Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 72 Europe Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 73 Europe Women’s Health Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 74 Europe Women’s Health Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 75 Germany Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 76 Germany Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 77 Germany Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 78 UK Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 79 U.K. Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 80 U.K. Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 81 France Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 82 France Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 83 France Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 84 Italy Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 85 Italy Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 86 Italy Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 87 Spain Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 88 Spain Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 89 Spain Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 90 Rest of Europe Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 91 Rest of Europe Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 92 Rest of Europe Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 93 Asia Pacific Women’s Health Market Attractiveness Index, 2023
Figure 94 Asia Pacific Women’s Health Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 95 Asia Pacific Women’s Health Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 96 Asia Pacific Women’s Health Market Share Forecast by Country, 2023 & 2033 (%)
Figure 97 Asia Pacific Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 98 Asia Pacific Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 99 Asia Pacific Women’s Health Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 100 Asia Pacific Women’s Health Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 101 Japan Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 102 Japan Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 103 Japan Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 104 China Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 105 China Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 106 China Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 107 India Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 108 India Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 109 India Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 110 South Korea Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 111 South Korea Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 112 South Korea Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 113 Australia Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 114 Australia Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 115 Australia Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 116 Rest of Asia Pacific Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 117 Rest of Asia Pacific Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 118 Rest of Asia Pacific Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 119 Latin America Women’s Health Market Attractiveness Index, 2023
Figure 120 Latin America Women’s Health Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 121 Latin America Women’s Health Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 122 Latin America Women’s Health Market Share Forecast by Country, 2023 & 2033 (%)
Figure 123 Latin America Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 124 Latin America Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 125 Latin America Women’s Health Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 126 Latin America Women’s Health Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 127 Brazil Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 128 Brazil Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 129 Brazil Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 130 Mexico Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 131 Mexico Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 132 Mexico Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 133 Rest of Latin America Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 134 Rest of Latin America Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 135 Rest of Latin America Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 136 MEA Women’s Health Market Attractiveness Index, 2023
Figure 137 MEA Women’s Health Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 138 MEA Women’s Health Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 139 MEA Women’s Health Market Share Forecast by Country, 2023 & 2033 (%)
Figure 140 MEA Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 141 MEA Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 142 MEA Women’s Health Market Forecast by Distribution Channel, 2023-2033 (US$ million, AGR %)
Figure 143 MEA Women’s Health Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 144 South Africa Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 145 South Africa Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 146 South Africa Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 147 GCC Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 148 GCC Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 149 GCC Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 150 Rest of MEA Women’s Health Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 151 Rest of MEA Women’s Health Market Forecast by Application, 2023-2033 (US$ million, AGR %)
Figure 152 Rest of MEA Women’s Health Market Share Forecast by Application, 2023 & 2033 (%)
Figure 153 Women’s Health Market: Company Share Analysis
Figure 154 Pfizer: Net Revenue, 2019-2021 (US$ million)
Figure 155 Pfizer: Regional Market Shares, 2021
Figure 156 Pfizer: Gross Profit, 2019-2021 (US$ million)
Figure 157 Pfizer: R&D, 2019-2021 (US$ million)
Figure 158 Merck: Net Revenue, 2019-2021 (US$ million)
Figure 159 Merck: Regional Market Shares, 2021
Figure 160 Merck: Income from Continuing Operations Before Taxes, 2019-2021 (US$ million)
Figure 161 Merck: R&D, 2019-2021 (US$ million)
Figure 162 Bayer Pharmaceuticals: Net Revenue, 2019-2021 (US$ million)
Figure 163 Bayer Pharmaceuticals: Regional Market Shares, 2021
Figure 164 Bayer Pharmaceuticals: EBITDA, 2019-2021 (US$ million)
Figure 165 Bayer Pharmaceuticals: R&D, 2019-2021 (US$ million)
Figure 166 Eli Lilly and Company: Net Revenue, 2019-2021 (US$ million)
Figure 167 Eli Lilly and Company: Regional Market Shares, 2021
Figure 168 Eli Lilly and Company: Net Income, 2019-2021 (US$ million)
Figure 169 Eli Lilly and Company: R&D, 2019-2021 (US$ million)
Figure 170 Amgen: Net Revenue, 2019-2021 (US$ million)
Figure 171 Amgen: Regional Market Shares, 2021
Figure 172 Amgen: Gross Profit, 2019-2021 (US$ million)
Figure 173 Amgen: R&D, 2019-2021 (US$ million)
Figure 174 AbbVie: Net Revenue, 2019-2021 (US$ million)
Figure 175 AbbVie: Regional Market Shares, 2021
Figure 176 AbbVie: Operating Earnings, 2019-2021 (US$ million)
Figure 177 AbbVie: R&D, 2019-2021 (US$ million)
Figure 178 Novartis: Net Revenue, 2019-2021 (US$ million)
Figure 179 Novartis: Regional Market Shares, 2021
Figure 180 Novartis: Gross Profit, 2019-2021 (US$ million)
Figure 181 Novartis: R&D, 2019-2021 (US$ million)
Figure 182 Ferring B.V.: Net Revenue, 2019-2021 (US$ million)
Figure 183 Ferring B.V.: Regional Market Shares, 2021
Figure 184 Ferring B.V.: Gross Profit, 2019-2021 (US$ million)
Figure 185 Ferring B.V.: R&D, 2019-2021 (US$ million)
List of Companies Profiled in the Report
Agile Therapeutics
Allergan/AbbVie
Amgen
Apothecus Pharmaceutical Corp.
Bayer Pharmaceuticals
Eli Lilly and Company
Ferring B.V.
Merck
Novartis
Pfizer
List of Other Companies Mentioned in the Report
AMAG Pharmaceuticals
BioSyent Inc.
Cipla
Essity
FurFischerre
Myovant Sciences
Neurocrine Biosciences
ObsEva
Organon Canada
Teva Pharmaceuticals
Theramex
XpresSpa Group, Inc.
Yuyuan Bioscience
List of Associations Mentioned in the Report
American College of Obstetricians and Gynaecologists
American Medical Women's Association
Asian Women for Health
Association for Women’s Health Care
European Institute of Women's Health
National Asian Women's Health Organization
Office on Women's Health
Society for Women's Health Research
Women's Healthcare Associates
World Health Organization
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
